{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:14:30Z","timestamp":1789913670820,"version":"4.0.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,1,12]],"date-time":"2011-01-12T00:00:00Z","timestamp":1294790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00277-010-1142-7","type":"journal-article","created":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T14:47:59Z","timestamp":1307112479000},"page":"837-842","source":"Crossref","is-referenced-by-count":23,"title":["Interactions of N-desmethyl imatinib, an active metabolite of imatinib, with P-glycoprotein in human leukemia cells"],"prefix":"10.1007","volume":"90","author":[{"given":"Petr","family":"Mlejnek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Dolezel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Kosztyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,12]]},"reference":[{"key":"1142_CR1","first-page":"100","volume":"56","author":"E Buchdunger","year":"1996","unstructured":"Buchdunger E, Zimmermann J, Mett H, Meyer T, M\u00fcller M, Druker BJ et al (1996) Inhibition of the Abl protein-kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res 56:100\u2013104","journal-title":"Cancer Res"},{"key":"1142_CR2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanninget S et al (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2:561\u2013566","journal-title":"Nat Med"},{"key":"1142_CR3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V96.3.925","volume":"96","author":"MC Heinrich","year":"2000","unstructured":"Heinrich MC, Griffith DJ, Druker BJ, Wait CL, Ott KA, Zigler AJ (2000) Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood 96:925\u2013932","journal-title":"Blood"},{"key":"1142_CR4","first-page":"3034","volume":"8","author":"R Dagher","year":"2002","unstructured":"Dagher R, Cohen M, Williams G, Rothmann M, Gobburu J, Robbie G et al (2002) Approval summary: imatinib mesylate in the treatment of metastatic and\/or unresectable malignant gastrointestinal stromal tumors. Clin Cancer Res 8:3034\u20133038","journal-title":"Clin Cancer Res"},{"key":"1142_CR5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/0091270003262101","volume":"44","author":"B Peng","year":"2004","unstructured":"Peng B, Dutreix C, Mehring G, Hayes MJ, Ben-Am M, Seiberling M et al (2004) Absolute bioavailability of imatinib (Glivec) orally versus intravenous infusion. J Clin Pharmacol 44:158\u2013162","journal-title":"J Clin Pharmacol"},{"key":"1142_CR6","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1124\/dmd.105.004283","volume":"33","author":"HP Gschwind","year":"2005","unstructured":"Gschwind HP, Pfaar U, Waldmeier F, Zollinger M, Sayer C, Zbinden P et al (2005) Metabolism and disposition of imatinib mesylate in healthy volunteers. Drug Metab Dospos 33:1503\u20131512","journal-title":"Drug Metab Dospos"},{"key":"1142_CR7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2141.1992.tb04608.x","volume":"82","author":"C Ludescher","year":"1992","unstructured":"Ludescher C, Thaler J, Drach D, Drach J, Spitaler M, Gattringer C (1992) Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123. Br J Hematol 82:161\u2013168","journal-title":"Br J Hematol"},{"key":"1142_CR8","doi-asserted-by":"crossref","unstructured":"Mlejnek P, Novak O, Dolezel P (2011) A non-radioactive assay for precise determination of intracellular levels of imatinib and its main metabolite in Bcr-Abl positive cells. Talanta (in press)","DOI":"10.1016\/j.talanta.2010.11.028"},{"key":"1142_CR9","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1016\/S0021-9258(18)42909-2","volume":"267","author":"B Sarkadi","year":"1992","unstructured":"Sarkadi B, Price EM, Boucher RC, Germann UA, Scarborough GA (1992) Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J Biol Chem 267:4854\u20134858","journal-title":"J Biol Chem"},{"key":"1142_CR10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1748-1716.2010.02087.x","volume":"199","author":"P Mlejnek","year":"2010","unstructured":"Mlejnek P, Dolezel P (2010) Induction of apoptosis by A3 adenosine receptor agonist N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukemia cells: a possible involvement of intracellular mechanism. Acta Physiol 199:171\u2013179","journal-title":"Acta Physiol"},{"key":"1142_CR11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immun Meth 65:55\u201363","journal-title":"J Immun Meth"},{"key":"1142_CR12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/cyto.990130802","volume":"13","author":"Z Darzynkiewicz","year":"1992","unstructured":"Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P et al (1992) Cytometry 13:795\u2013808","journal-title":"Cytometry"},{"key":"1142_CR13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0925-4439(02)00095-9","volume":"1587","author":"T Hegedus","year":"2002","unstructured":"Hegedus T, Orfi L, Seprodi A, V\u00e1radi A, Sarkadi B, K\u00e9ri G (2002) Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1. Biochim Biophys Acta 1587:318\u2013325","journal-title":"Biochim Biophys Acta"},{"key":"1142_CR14","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1182\/blood.V101.6.2368","volume":"101","author":"FX Mahon","year":"2003","unstructured":"Mahon FX, Belloc F, Lagarde V, Chollet C, Moreau-Gaudry F, Reiffers J et al (2003) MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models. Blood 101:2368\u20132373","journal-title":"Blood"},{"key":"1142_CR15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2407-8-51","volume":"8","author":"R Tang","year":"2008","unstructured":"Tang R, Faussat AM, Perrot JY, Marjanovic Z, Cohen S, Storme T (2008) Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML). BMC Cancer 8:51\u201359","journal-title":"BMC Cancer"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-010-1142-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-010-1142-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-010-1142-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T14:49:42Z","timestamp":1637765382000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-010-1142-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,12]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1142"],"URL":"https:\/\/doi.org\/10.1007\/s00277-010-1142-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,12]]}}}